lncRNA MALAT1, HOTTIP and PVT1 as predictors for predicting the efficacy of GEM based chemotherapy in first-line treatment of pancreatic cancer patients

This study evaluated the lnc-RNAs as biomarker to predict efficacy of gemcitabine (GEM) based chemotherapy as the first-line treatment for locally advanced or advanced pancreatic cancer patients. We selected 62 patients with GEM based chemotherapy and divided two groups according to the PFS. We foun...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Cui-Juan, Shi, Sheng-Bin, Tian, Jing, Xu, Jun, Niu, Zuo-Xing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707009/
https://www.ncbi.nlm.nih.gov/pubmed/29221115
http://dx.doi.org/10.18632/oncotarget.19345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5707009/
https://www.ncbi.nlm.nih.gov/pubmed/29221115
http://dx.doi.org/10.18632/oncotarget.19345

Ejemplares similares